Trader consensus on a 95.8% implied probability of no new pandemic in 2026 reflects the absence of any novel pathogen achieving sustained global human-to-human transmission through mid-October. The dominant concern remains the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, with over 8,700 confirmed cases and a 48% case fatality ratio as of early October, plus limited spread to Kenya; however, direct-contact transmission and rapid contact-tracing have kept it regionally contained without pandemic characteristics. Seasonal influenza surveillance, including H5N1 and H9N2 avian strains, shows occasional zoonotic spillover but no evidence of efficient airborne human spread. Measles and dengue resurgences are vaccine- or vector-linked and geographically limited. With roughly ten weeks remaining and enhanced WHO genomic surveillance in place, realistic shifts would require an undetected zoonotic jump or rapid viral adaptation producing high transmissibility before year-end.